MCRB
Price
$9.54
Change
+$0.03 (+0.32%)
Updated
May 2, 02:44 PM (EDT)
Capitalization
82.91M
5 days until earnings call
OTLK
Price
$1.58
Change
+$0.01 (+0.64%)
Updated
May 2, 02:42 PM (EDT)
Capitalization
51.21M
Ad is loading...

MCRB vs OTLK

Header iconMCRB vs OTLK Comparison
Open Charts MCRB vs OTLKBanner chart's image
Seres Therapeutics
Price$9.54
Change+$0.03 (+0.32%)
Volume$100
Capitalization82.91M
Outlook Therapeutics
Price$1.58
Change+$0.01 (+0.64%)
Volume$100
Capitalization51.21M
MCRB vs OTLK Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCRB vs. OTLK commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Buy and OTLK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (MCRB: $9.50 vs. OTLK: $1.57)
Brand notoriety: MCRB and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 53% vs. OTLK: 55%
Market capitalization -- MCRB: $82.91M vs. OTLK: $51.21M
MCRB [@Biotechnology] is valued at $82.91M. OTLK’s [@Biotechnology] market capitalization is $51.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileOTLK’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • OTLK’s FA Score: 0 green, 5 red.
According to our system of comparison, both MCRB and OTLK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 6 TA indicator(s) are bullish while OTLK’s TA Score has 6 bullish TA indicator(s).

  • MCRB’s TA Score: 6 bullish, 2 bearish.
  • OTLK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MCRB is a better buy in the short-term than OTLK.

Price Growth

MCRB (@Biotechnology) experienced а +4.63% price change this week, while OTLK (@Biotechnology) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +8.32%, and the average quarterly price growth was -5.52%.

Reported Earning Dates

MCRB is expected to report earnings on Aug 05, 2025.

OTLK is expected to report earnings on May 15, 2024.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($82.9M) has a higher market cap than OTLK($51.2M). OTLK YTD gains are higher at: -16.931 vs. MCRB (-42.840). OTLK has higher annual earnings (EBITDA): -83.38M vs. MCRB (-120.3M). OTLK has less debt than MCRB: OTLK (31M) vs MCRB (91.6M). MCRB (0) and OTLK (0) have equivalent revenues.
MCRBOTLKMCRB / OTLK
Capitalization82.9M51.2M162%
EBITDA-120.3M-83.38M144%
Gain YTD-42.840-16.931253%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A5.7M-
Total Debt91.6M31M295%
FUNDAMENTALS RATINGS
MCRB vs OTLK: Fundamental Ratings
MCRB
OTLK
OUTLOOK RATING
1..100
2731
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9464
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (57) in the Biotechnology industry is in the same range as OTLK (86). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

MCRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

MCRB's SMR Rating (99) in the Biotechnology industry is in the same range as OTLK (99). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

OTLK's Price Growth Rating (64) in the Biotechnology industry is in the same range as MCRB (94). This means that OTLK’s stock grew similarly to MCRB’s over the last 12 months.

OTLK's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MCRB (100). This means that OTLK’s stock grew similarly to MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBOTLK
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSGS60.01-0.12
-0.20%
CSG Systems International
RACE460.12-1.66
-0.36%
Ferrari NV
TACT3.46-0.02
-0.57%
TransAct Technologies
MTH66.95-1.19
-1.75%
Meritage Homes Corporation
AEHR8.36-0.17
-1.99%
Aehr Test Systems

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
-2.06%
ORMP - MCRB
42%
Loosely correlated
-2.16%
AXON - MCRB
38%
Loosely correlated
+1.27%
AMRN - MCRB
36%
Loosely correlated
+2.04%
ARRY - MCRB
34%
Loosely correlated
+7.74%
ALNY - MCRB
34%
Loosely correlated
-3.08%
More

OTLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with HEPA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then HEPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
N/A
HEPA - OTLK
34%
Loosely correlated
+0.93%
CYTK - OTLK
33%
Loosely correlated
+0.19%
PDSB - OTLK
33%
Loosely correlated
-5.00%
MCRB - OTLK
32%
Poorly correlated
-2.06%
VIR - OTLK
31%
Poorly correlated
-0.65%
More